Literature DB >> 15159211

Metabolomics--a new exciting field within the "omics" sciences.

Katja Dettmer, Bruce D Hammock.   

Abstract

Mesh：

Year:  2004        PMID： 15159211      PMCID： PMC1241997          DOI： 10.1289/ehp.112-1241997

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN： 0091-6765            Impact factor:   9.031


× No keyword cloud information.
  5 in total

Review 1.  Metabolomics--the link between genotypes and phenotypes.

Authors:  Oliver Fiehn
Journal:  Plant Mol Biol       Date:  2002-01       Impact factor: 4.076

2.  Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids.

Authors:  Robert S Plumb; Chris L Stumpf; Jennifer H Granger; Jose Castro-Perez; John N Haselden; Gordon J Dear
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

Review 3.  Metabonomics: a platform for studying drug toxicity and gene function.

Authors:  Jeremy K Nicholson; John Connelly; John C Lindon; Elaine Holmes
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

Review 4.  Metabolomics in systems biology.

Authors:  Wolfram Weckwerth
Journal:  Annu Rev Plant Biol       Date:  2003       Impact factor: 26.379

Review 5.  Toward the implementation of metabolomic assessments of human health and nutrition.

Authors:  Steven M Watkins; J Bruce German
Journal:  Curr Opin Biotechnol       Date:  2002-10       Impact factor: 9.740
  5 in total
  51 in total

1.  Preterm neonatal urinary renal developmental and acute kidney injury metabolomic profiling: an exploratory study.

Authors:  Kelly Mercier; Susan McRitchie; Wimal Pathmasiri; Andrew Novokhatny; Rajesh Koralkar; David Askenazi; Patrick D Brophy; Susan Sumner
Journal:  Pediatr Nephrol       Date:  2016-07-19       Impact factor: 3.714

Review 2.  Mass spectrometry-based metabolomics.

Authors:  Katja Dettmer; Pavel A Aronov; Bruce D Hammock
Journal:  Mass Spectrom Rev       Date:  2007 Jan-Feb       Impact factor: 10.946

Review 3.  Review of mass spectrometry-based metabolomics in cancer research.

Authors:  David B Liesenfeld; Nina Habermann; Robert W Owen; Augustin Scalbert; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-04       Impact factor: 4.254

Review 4.  Metabolomics in pediatric nephrology: emerging concepts.

Authors:  Mina H Hanna; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2014-07-17       Impact factor: 3.714

5.  Changes of serum amino acid profiles by an epidermal growth factor receptor mutation and benzo[a]pyrene in mouse lung tumorigenesis.

Authors:  Pinpin Lin; Yi-Rong Chen; Chao-Yu Chen; Ya-Ting Chang; Jhih-Sheng Chen; Ming-Hsien Tsai; Cheng-Chin Kuo; Hui-Ling Lee
Journal:  Toxicol Res (Camb)       Date:  2016-05-17       Impact factor: 3.524

Review 6.  Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes.

Authors:  Jane Ha; Yeongkeun Kwon; Sungsoo Park
Journal:  Obes Surg       Date:  2021-07-27       Impact factor: 4.129

Review 7.  Saliva: diagnostics and therapeutic perspectives.

Authors:  N Spielmann; D T Wong
Journal:  Oral Dis       Date:  2010-12-02       Impact factor: 3.511

8.  Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model.

Authors:  Andrew C Beckstrom; Elizabeth M Humston; Laura R Snyder; Robert E Synovec; Sandra E Juul
Journal:  J Chromatogr A       Date:  2011-02-25       Impact factor: 4.759

9.  Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules.

Authors:  Irene Kouskoumvekaki; Gianni Panagiotou
Journal:  J Biomed Biotechnol       Date:  2010-09-28

10.  Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.

Authors:  Tatjana Abaffy; Robert Duncan; Daniel D Riemer; Olaf Tietje; George Elgart; Clara Milikowski; R Anthony DeFazio
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.